Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823

Por Liu, Wei, Guo, Qing-Long, You, Qi-Dong, Zhao, Li, Gu, Hong-Yan, Yuan, Sheng-Tao
Publicado no World J Gastroenterol (2005)

Changes of integrin expression in rat hepatocarcinogenesis induced by 3’-Me-DAB

Por Yuan, Sheng Tao, Hu, Xi Qi, Lu, Jian Ping, KeiKi, Hayashi, Zhai, Wei Rong, Zhang, Yue E
Publicado no World J Gastroenterol (2000)

Topotecan inhibits cancer cell migration by down-regulation of chemokine CC motif receptor 7 and matrix metalloproteinases

Por Lin, Sen-sen, Sun, Li, Zhang, Yan-kai, Zhao, Ren-ping, Liang, Wen-lu, Yuan, Sheng-tao, Zhang, Lu-yong
Publicado em 2009

Nuclear Magnetic Resonance-Based Metabolomics Approach to Evaluate the Prevention Effect of Camellia nitidissima Chi on Colitis-Associated Carcinogenesis

Por Li, Ming-Hui, Du, Hong-Zhi, Kong, Gui-Ju, Liu, Li-Bao, Li, Xin-Xin, Lin, Sen-Sen, Jia, Ai-Qun, Yuan, Sheng-Tao, Sun, Li, Wang, Jun-Song
Publicado no Front Pharmacol (2017)

Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo

Por Yu, Xiao-Wen, Lin, Sensen, Du, Hong-Zhi, Zhao, Ren-Ping, Feng, Shu-Yun, Yu, Bo-Yang, Zhang, Lu-Yong, Li, Rui-Ming, Qian, Chang-Min, Luo, Xue-Jun, Yuan, Sheng-Tao, Sun, Li
Publicado no Oncotarget (2016)